TY - JOUR
T1 - Phytochemical and pharmacological properties of asperuloside, a systematic review
AU - Manzione, Maria Giulia
AU - Martorell, Miquel
AU - Sharopov, Farukh
AU - Bhat, Namrata Ganesh
AU - Kumar, Nanjangud Venkatesh Anil
AU - Fokou, Patrick Valere Tsouh
AU - Pezzani, Raffaele
PY - 2020/9/15
Y1 - 2020/9/15
N2 - Plants are a natural source of bioactive compounds such as secondary metabolites. These molecules, also called phytochemicals, are fundamental for plant survival and often show therapeutic properties used for the treatment of human diseases. Asperuloside is a secondary metabolite which belongs to iridoid glycosides and is commonly present in the plant family Rubiaceae. In this review we aim to summarize the scientific knowledge on asperuloside, with a special emphasis on its pharmacological properties as anti-viral, anti-malarial, anti-protozoal, anti-tumorigenic, anti-hypertensive, anti-obesity, immunomodulatory, anti-inflammatory and antioxidant agent. Preclinical studies in animal models suggest that asperuloside has therapeutic potential that could be evaluated in humans. However, despite its tangible phytochemical characteristics, no clinical trial has been performed so far. Thus, we hope that this review will facilitate scientific dissemination of asperuloside pharmacological properties and encourage researchers to evaluate both pharmacokinetic and toxicity of asperuloside in animal models. This will be the first step towards clinical studies in humans.
AB - Plants are a natural source of bioactive compounds such as secondary metabolites. These molecules, also called phytochemicals, are fundamental for plant survival and often show therapeutic properties used for the treatment of human diseases. Asperuloside is a secondary metabolite which belongs to iridoid glycosides and is commonly present in the plant family Rubiaceae. In this review we aim to summarize the scientific knowledge on asperuloside, with a special emphasis on its pharmacological properties as anti-viral, anti-malarial, anti-protozoal, anti-tumorigenic, anti-hypertensive, anti-obesity, immunomodulatory, anti-inflammatory and antioxidant agent. Preclinical studies in animal models suggest that asperuloside has therapeutic potential that could be evaluated in humans. However, despite its tangible phytochemical characteristics, no clinical trial has been performed so far. Thus, we hope that this review will facilitate scientific dissemination of asperuloside pharmacological properties and encourage researchers to evaluate both pharmacokinetic and toxicity of asperuloside in animal models. This will be the first step towards clinical studies in humans.
UR - http://www.scopus.com/inward/record.url?scp=85088266587&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088266587&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2020.173344
DO - 10.1016/j.ejphar.2020.173344
M3 - Review article
C2 - 32659300
AN - SCOPUS:85088266587
SN - 0014-2999
VL - 883
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
M1 - 173344
ER -